 BEVERLY, Mass., Oct. 01, 2021 GLOBE NEWSWIRE -- LexaGene Holdings, Inc., OTCQB: LXXGF; TSX-V: LXG LexaGene or the Company, a commercial molecular diagnostics company selling a point-of-need highly multiplexed in-clinic PCR system with results in approximately two hours, today announced it will be featured at three investor relations conferences in early October. LexaGene management will also participate in one-on-one meetings at each conference. 